FOLFOX-aflibercept followed by maintenance therapy with fluoropyrimidine-aflibercept as first-line therapy in patients with metastatic colorectal cancer: A GERCOR single-arm phase II study (VELVET).
2015 ◽
Vol 33
(15_suppl)
◽
pp. 3567-3567
Keyword(s):
Phase Ii
◽
2001 ◽
Vol 37
◽
pp. S272
◽